Funds holding Allogene Therapeutics Inc
ISIN US0197701065 · United States
- Fund holders
- 141
- Of which ETFs
- 22 119 other funds
- Value held
- 120.5M $
- Share of capital
- 14.4 % of 345.5M shares on Aug 10, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| U.S. Small Cap Equity Fund RUSSELL INVESTMENT FUNDS | 12,134 | 29.6K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| WisdomTree BioRevolution Fund WisdomTree Trust | 11,574 | 28.2K $ | 1.25 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Nationwide Small Cap Index Fund Nationwide Mutual Funds | 11,478 | 24.4K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Strategic Equity Allocation Trust John Hancock Variable Insurance Trust | 10,631 | 25.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 10,377 | 28.8K $ | 0.03 % | 0.00 % | as of Feb 28, 2026 ↗ |
| VIP Extended Market Index Portfolio Variable Insurance Products Fund II | 10,375 | 25.3K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| LVIP Dimensional U.S. Core Equity 1 Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 10,092 | 24.6K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| VANGUARD RUSSELL 3000 INDEX FUND VANGUARD SCOTTSDALE FUNDS | 9,870 | 27.4K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Voya VACS Index Series SC Portfolio Voya VARIABLE PORTFOLIOS INC | 9,820 | 24K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Ultra Russell2000 ProShares Trust | 9,521 | 26.5K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares UltraPro Russell2000 ProShares Trust | 9,491 | 26.4K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| SA U.S. Small Company Fund SA FUNDS INVESTMENT TRUST | 8,990 | 21.9K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Small-Cap Equity Portfolio PACIFIC SELECT FUND | 7,237 | 17.7K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| LVIP Dimensional U.S. Core Equity 2 Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 7,123 | 17.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Russell 2000 High Income ETF ProShares Trust | 6,663 | 18.5K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Nationwide Fundamental All Cap Equity Portfolio Nationwide Mutual Funds | 6,234 | 13.3K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| iShares Total U.S. Stock Market Index Fund BlackRock Funds | 5,719 | 12.2K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| EQ/Franklin Small Cap Value Managed Volatility Portfolio EQ Advisors Trust | 5,657 | 13.8K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SmallCap Value Fund II Principal Funds, Inc | 5,158 | 11K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Morgan Stanley Pathway Small-Mid Cap Equity ETF MORGAN STANLEY PATHWAY FUNDS | 5,063 | 14.1K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 4,082 | 10K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| AZL DFA U.S. Core Equity Fund Allianz Variable Insurance Products Trust | 4,027 | 9.8K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| VIP Total Market Index Portfolio Variable Insurance Products Fund II | 3,917 | 9.6K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Total Return V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 3,701 | 9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Destinations Small-Mid Cap Equity Fund Brinker Capital Destinations Trust | 3,487 | 9.7K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Fidelity Flex Small Cap Focused Index Fund Fidelity Salem Street Trust | 2,848 | 6.1K $ | 0.04 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Penn Series Small Cap Index Fund Penn Series Funds Inc | 2,800 | 6.8K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| TIAA Separate Account VA-1 - Stock Index Account TIAA Separate Account VA-1 | 2,417 | 5.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ULTRA SMALL CAP PROFUND ProFunds | 1,760 | 3.7K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 1,415 | 3.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Nuveen Life Stock Index Fund TIAA-CREF Life Funds | 1,319 | 3.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 773 | 1.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 521 | 1.3K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 394 | 961.4 $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 356 | 868.6 $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 284 | 604.9 $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 211 | 514.8 $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 158 | 439.2 $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 154 | 375.8 $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 48 | 133.4 $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 40 | 97.6 $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| WisdomTree BioRevolution Fund WisdomTree Trust | 1.25 % | as of Mar 31, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 1.04 % | as of Apr 30, 2026 ↗ |
| Invesco NASDAQ Future Gen 200 ETF Invesco Exchange-Traded Fund Trust II | 0.90 % | as of Feb 28, 2026 ↗ |
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 0.50 % | as of Mar 31, 2026 ↗ |
| Horizon Kinetics Medical ETF Listed Funds Trust | 0.24 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 0.17 % | as of Mar 31, 2026 ↗ |
| PROFUND VP BIOTECHNOLOGY ProFunds | 0.17 % | as of Mar 31, 2026 ↗ |
| NVIT Small Cap Value Fund Nationwide Variable Insurance Trust | 0.16 % | as of Mar 31, 2026 ↗ |
| EQ/T.Rowe Price Health Sciences Portfolio EQ Advisors Trust | 0.14 % | as of Mar 31, 2026 ↗ |
| Health Sciences Trust John Hancock Variable Insurance Trust | 0.14 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 141 | +17 | 49,773,957 | +37.8 % |
| 2026Q1 | 124 | -9 | 36,111,122 | -1.3 % |
| 2025Q4 | 133 | +5 | 36,572,295 | -21.2 % |
| 2025Q3 | 128 | -25 | 46,388,929 | -15.9 % |
| 2025Q2 | 153 | -13 | 55,166,838 | -14.2 % |
| 2025Q1 | 166 | -10 | 64,329,116 | -7.3 % |
| 2024Q4 | 176 | -12 | 69,369,234 | -7.2 % |
| 2024Q3 | 188 | -17 | 74,724,305 | +21.0 % |
| 2024Q2 | 205 | +12 | 61,745,454 | +15.9 % |
| 2024Q1 | 193 | -5 | 53,297,706 | -10.6 % |
| 2023Q4 | 198 | 59,598,564 |
Institutional managers
202 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| Pfizer Inc | 22,032,040 | 49.8M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 19,091,095 | 46.6M $ | as of Mar 31, 2026 |
| TPG GP A, LLC | 18,716,306 | 45.7M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 8,660,306 | 21.1M $ | as of Mar 31, 2026 |
| PRIMECAP MANAGEMENT CO/CA/ | 8,379,840 | 20.4M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 6,793,620 | 16.6M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 5,380,902 | 13.1K $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 5,375,456 | 13.1M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 4,124,178 | 10.1M $ | as of Mar 31, 2026 |
| Frazier Life Sciences Management, L.P. | 3,796,668 | 9.3M $ | as of Mar 31, 2026 |
| Woodline Partners LP | 3,501,078 | 8.5M $ | as of Mar 31, 2026 |
| Patient Square Capital LP | 3,450,000 | 8.4M $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 3,447,984 | 8.4M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 3,322,053 | 8.1M $ | as of Mar 31, 2026 |
| Candriam S.C.A. | 2,997,318 | 7.3M $ | as of Mar 31, 2026 |
| Wildcat Capital Management, LLC | 2,920,787 | 7.1M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 2,766,244 | 6.7M $ | as of Mar 31, 2026 |
| D. E. Shaw & Co., Inc. | 2,763,776 | 6.7M $ | as of Mar 31, 2026 |
| Boxer Capital Management, LLC | 2,725,000 | 6.6M $ | as of Mar 31, 2026 |
| AQR CAPITAL MANAGEMENT LLC | 2,484,780 | 6.1M $ | as of Mar 31, 2026 |
| Nuveen, LLC | 2,315,092 | 5.6M $ | as of Mar 31, 2026 |
| MPM BIOIMPACT LLC | 2,242,933 | 5.5M $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 2,139,328 | 5.2M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 2,134,473 | 5.2M $ | as of Mar 31, 2026 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 2,013,508 | 4.9M $ | as of Mar 31, 2026 |
Declared shareholders of Allogene Therapeutics Inc
There are 5 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Arie Belldegrun, M.D. and 5 others | 5.40 % | 13,466,383 | as of Mar 31, 2026 · SCHEDULE 13G |
| David D. Chang, M.D., Ph.D. and 3 others | 4.90 % | 12,297,354 | as of Mar 31, 2026 · SCHEDULE 13G |
| Frazier Life Sciences Public Fund, L.P. and 13 others | 4.70 % | 16,205,306 | as of Apr 16, 2026 · SCHEDULE 13G |
| Citadel Advisors LLC and 6 others | 2.80 % | 6,855,120 | as of Mar 31, 2026 · SCHEDULE 13G |
| Lynx1 Capital Management LP and 1 other | 0.00 % | 0 | as of Dec 31, 2025 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding Allogene Therapeutics Inc". https://titelia.com/en/stocks/allogene-therapeutics-inc-US0197701065